Cargando…

Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3

The aim of this study was to evaluate some immunological patterns involved in natural and acquired resistance against MHV3 using the original model of genetically modified lines of mice selected for high (H(III)) and low (L(III)) antibody responsiveness. As previously shown, a lower pre-existing ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassão, Ruth C., Consales, Cleide A., Sant'Anna, Osvaldo A., Pereira, Carlos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Urban & Fischer Verlag. Published by Elsevier GmbH 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134454/
https://www.ncbi.nlm.nih.gov/pubmed/12952350
http://dx.doi.org/10.1078/0171-2985-00239
_version_ 1783517839743778816
author Vassão, Ruth C.
Consales, Cleide A.
Sant'Anna, Osvaldo A.
Pereira, Carlos A.
author_facet Vassão, Ruth C.
Consales, Cleide A.
Sant'Anna, Osvaldo A.
Pereira, Carlos A.
author_sort Vassão, Ruth C.
collection PubMed
description The aim of this study was to evaluate some immunological patterns involved in natural and acquired resistance against MHV3 using the original model of genetically modified lines of mice selected for high (H(III)) and low (L(III)) antibody responsiveness. As previously shown, a lower pre-existing anti-MHV antibody level was found in susceptible H(III) mice as compared to resistant L(III) mice. Mortality rates of the F(1) (H×L) hybrids and F(2) and backcross segregants reflected co-dominance of both characters and the survivors had higher pre-existing anti-MHV antibody titers. The present data show that both lines had the potential to synthesize antibodies and that the resistance acquired by the susceptible H(III) mice paralleled the antibody synthesis. Nevertheless, higher antibody titers were necessary to confer resistance in H(III) mice than in L(III) ones. When compared to uvMHV3, a single immunization with a related infectious MHV strain induced a higher antibody synthesis and led the H(III) mice to resist the MHV3 challenge. A direct correlation between the antibody level and resistance to infection was always observed in H(III) mice. Although mounting a Th2 response as indicated by IgG1 responses, they were also able to readily synthesize large amounts of IgG2a antibodies after immunization or during infection, reflecting a Th1 response. The transfer of anti-MHV antibodies to susceptible H(III) mice was capable of conferring resistance to MHV3, providing the antibodies were present before virus infection and in large amounts. The resistance and the survival time of these animals increased with the level of antibody administered. If these direct and clear data suggest that H(III) mice can acquire resistance through antibodies, the basis of the resistance of the resistant L(III) mice may rely on mechanisms less dependent on antibodies.
format Online
Article
Text
id pubmed-7134454
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Urban & Fischer Verlag. Published by Elsevier GmbH
record_format MEDLINE/PubMed
spelling pubmed-71344542020-04-08 Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3 Vassão, Ruth C. Consales, Cleide A. Sant'Anna, Osvaldo A. Pereira, Carlos A. Immunobiology Article The aim of this study was to evaluate some immunological patterns involved in natural and acquired resistance against MHV3 using the original model of genetically modified lines of mice selected for high (H(III)) and low (L(III)) antibody responsiveness. As previously shown, a lower pre-existing anti-MHV antibody level was found in susceptible H(III) mice as compared to resistant L(III) mice. Mortality rates of the F(1) (H×L) hybrids and F(2) and backcross segregants reflected co-dominance of both characters and the survivors had higher pre-existing anti-MHV antibody titers. The present data show that both lines had the potential to synthesize antibodies and that the resistance acquired by the susceptible H(III) mice paralleled the antibody synthesis. Nevertheless, higher antibody titers were necessary to confer resistance in H(III) mice than in L(III) ones. When compared to uvMHV3, a single immunization with a related infectious MHV strain induced a higher antibody synthesis and led the H(III) mice to resist the MHV3 challenge. A direct correlation between the antibody level and resistance to infection was always observed in H(III) mice. Although mounting a Th2 response as indicated by IgG1 responses, they were also able to readily synthesize large amounts of IgG2a antibodies after immunization or during infection, reflecting a Th1 response. The transfer of anti-MHV antibodies to susceptible H(III) mice was capable of conferring resistance to MHV3, providing the antibodies were present before virus infection and in large amounts. The resistance and the survival time of these animals increased with the level of antibody administered. If these direct and clear data suggest that H(III) mice can acquire resistance through antibodies, the basis of the resistance of the resistant L(III) mice may rely on mechanisms less dependent on antibodies. Urban & Fischer Verlag. Published by Elsevier GmbH 2003 2004-11-10 /pmc/articles/PMC7134454/ /pubmed/12952350 http://dx.doi.org/10.1078/0171-2985-00239 Text en © 2003 Urban & Fischer Verlag Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Vassão, Ruth C.
Consales, Cleide A.
Sant'Anna, Osvaldo A.
Pereira, Carlos A.
Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3
title Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3
title_full Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3
title_fullStr Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3
title_full_unstemmed Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3
title_short Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3
title_sort antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134454/
https://www.ncbi.nlm.nih.gov/pubmed/12952350
http://dx.doi.org/10.1078/0171-2985-00239
work_keys_str_mv AT vassaoruthc antibodyresponsivenessduringimmunizationandchallengeofgeneticallymodifiedantibodyrespondermicewithmurinehepatitisvirus3
AT consalescleidea antibodyresponsivenessduringimmunizationandchallengeofgeneticallymodifiedantibodyrespondermicewithmurinehepatitisvirus3
AT santannaosvaldoa antibodyresponsivenessduringimmunizationandchallengeofgeneticallymodifiedantibodyrespondermicewithmurinehepatitisvirus3
AT pereiracarlosa antibodyresponsivenessduringimmunizationandchallengeofgeneticallymodifiedantibodyrespondermicewithmurinehepatitisvirus3